WEST PHARMACEUTICAL SERVICES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$1.50 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2022-02-22
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-12-31 was -$600.00K.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-09-30 was -$100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-06-30 was -$100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-03-31 was -$700.00K.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2021 was -$1.50M.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2020 was -$1.20M.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2019 was -$2.10M.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2018 was -$2.60M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$700.00K derived: sum of 2 quarters · filed 2022-02-22 | -$800.00K derived: sum of 3 quarters · filed 2022-02-22 | -$1.50M 10-K · filed 2022-02-22 | ||||
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$200.00K derived: sum of 2 quarters · filed 2021-10-28 | -$900.00K 10-Q · filed 2021-10-28 | -$1.20M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2021-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$800.00K 10-Q · filed 2021-07-30 | -$1.10M derived: sum of 3 quarters · filed 2022-02-22 | -$1.90M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2021-03-31 | -$700.00K 10-Q · filed 2021-04-30 | -$1.00M derived: sum of 2 quarters · filed 2022-02-22 | -$1.80M derived: sum of 3 quarters · filed 2022-02-22 | -$1.90M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$1.10M derived: sum of 2 quarters · filed 2022-02-22 | -$1.20M derived: sum of 3 quarters · filed 2022-02-22 | -$1.20M 10-K · filed 2022-02-22 | ||||
| 2020-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | -$900.00K derived: sum of 2 quarters · filed 2020-10-23 | -$900.00K 10-Q · filed 2020-10-23 | -$3.40M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2020-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | -$100.00K 10-Q · filed 2020-07-24 | -$2.60M derived: sum of 3 quarters · filed 2021-02-23 | -$2.50M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2020-04-24 | -$2.50M derived: sum of 2 quarters · filed 2021-02-23 | -$2.40M derived: sum of 3 quarters · filed 2021-02-23 | -$2.30M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$2.40M derived: sum of 2 quarters · filed 2021-02-23 | -$2.30M derived: sum of 3 quarters · filed 2021-02-23 | -$2.10M 10-K · filed 2021-02-23 | $2.10M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $200.00K derived: sum of 2 quarters · filed 2019-10-29 | $400.00K 10-Q · filed 2019-10-29 | -$3.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2019-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $300.00K 10-Q · filed 2019-07-29 | -$3.10M derived: sum of 3 quarters · filed 2020-02-24 | -$2.90M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-08 | -$3.20M derived: sum of 2 quarters · filed 2020-02-24 | -$3.00M derived: sum of 3 quarters · filed 2020-02-24 | -$2.70M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$3.20M derived: sum of 2 quarters · filed 2020-02-24 | -$2.90M derived: sum of 3 quarters · filed 2020-02-24 | -$2.60M 10-K · filed 2020-02-24 | ||||
| 2018-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $500.00K derived: sum of 2 quarters · filed 2018-10-30 | $800.00K 10-Q · filed 2018-10-30 | -$2.10M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2018-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $600.00K 10-Q · filed 2018-07-31 | -$2.30M derived: sum of 3 quarters · filed 2019-02-28 | -$2.50M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2018-03-31 | $300.00K 10-Q · filed 2018-05-08 | -$2.60M derived: sum of 2 quarters · filed 2019-02-28 | -$2.80M derived: sum of 3 quarters · filed 2019-02-28 | -$2.40M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$3.10M derived: sum of 2 quarters · filed 2019-02-28 | -$2.70M derived: sum of 3 quarters · filed 2019-02-28 | -$2.40M 10-K · filed 2019-02-28 | ||||
| 2017-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $200.00K derived: sum of 2 quarters · filed 2017-10-31 | $500.00K 10-Q · filed 2017-10-31 | $900.00K derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2017-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $700.00K 10-Q · filed 2017-08-01 | $1.10M derived: sum of 3 quarters · filed 2018-02-26 | $1.10M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2017-03-31 | $300.00K 10-Q · filed 2017-05-05 | $700.00K derived: sum of 2 quarters · filed 2018-02-26 | $700.00K derived: sum of 3 quarters · filed 2018-02-26 | $2.40M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $400.00K derived: sum of 2 quarters · filed 2018-02-26 | $2.10M derived: sum of 3 quarters · filed 2018-02-26 | $2.30M 10-K · filed 2018-02-26 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $1.70M derived: sum of 2 quarters · filed 2016-10-31 | $1.90M 10-Q · filed 2016-10-31 | $2.20M derived: sum of 4 quarters · filed 2017-05-05 | ||||
| 2016-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $1.90M 10-Q · filed 2016-08-01 | $2.20M derived: sum of 3 quarters · filed 2017-05-05 | $2.70M derived: sum of 4 quarters · filed 2017-05-05 | ||||
| 2016-03-31 | $200.00K 10-Q · filed 2017-05-05 | $500.00K derived: sum of 2 quarters · filed 2017-05-05 | $1.00M derived: sum of 3 quarters · filed 2017-05-05 | $1.10M derived: sum of 4 quarters · filed 2017-05-05 | ||||
| 2015-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $800.00K derived: sum of 2 quarters · filed 2017-02-28 | $900.00K derived: sum of 3 quarters · filed 2017-02-28 | $1.10M 10-K · filed 2017-02-28 | ||||
| 2015-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $600.00K derived: sum of 2 quarters · filed 2016-10-31 | $800.00K 10-Q · filed 2016-10-31 | $800.00K derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2015-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $300.00K 10-Q · filed 2016-08-01 | $300.00K derived: sum of 3 quarters · filed 2016-08-01 | $600.00K derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2015-03-31 | $200.00K 10-Q · filed 2016-05-06 | -$200.00K 10-Q · filed 2015-05-06 | $200.00K derived: sum of 2 quarters · filed 2016-05-06 | $500.00K derived: sum of 3 quarters · filed 2016-05-06 | $1.60M derived: sum of 4 quarters · filed 2016-05-06 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $300.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.40M derived: sum of 3 quarters · filed 2016-02-26 | $1.00M 10-K · filed 2016-02-26 | ||||
| 2014-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $1.40M derived: sum of 2 quarters · filed 2015-11-02 | $1.00M 10-Q · filed 2015-11-02 | -$1.00M 10-Q · filed 2014-11-03 | $2.60M derived: sum of 4 quarters · filed 2015-11-02 | |||
| 2014-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $700.00K 10-Q · filed 2015-08-03 | -$700.00K 10-Q · filed 2014-08-01 | $2.30M derived: sum of 3 quarters · filed 2015-08-03 | $2.00M derived: sum of 4 quarters · filed 2015-08-03 | |||
| 2014-03-31 | -$400.00K 10-Q · filed 2015-05-06 | $1.20M derived: sum of 2 quarters · filed 2015-05-06 | $900.00K derived: sum of 3 quarters · filed 2015-05-06 | $700.00K derived: sum of 4 quarters · filed 2015-05-06 | ||||
| 2013-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.30M derived: sum of 2 quarters · filed 2015-02-25 | $1.10M derived: sum of 3 quarters · filed 2015-02-25 | $1.10M 10-K · filed 2015-02-25 | $1.00M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$500.00K derived: sum of 2 quarters · filed 2014-11-03 | -$500.00K 10-Q · filed 2014-11-03 | $1.60M derived: sum of 4 quarters · filed 2014-11-03 | ||||
| 2013-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$200.00K 10-Q · filed 2014-08-01 | $1.90M derived: sum of 3 quarters · filed 2014-08-01 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $2.10M derived: sum of 2 quarters · filed 2014-05-08 | ||||||
| 2012-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.20M 10-K · filed 2014-02-27 | ||||||
| 2012-09-30 | -$900.00K 10-Q · filed 2013-11-04 | |||||||
| 2011-12-31 | -$300.00K 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |